Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
Yaqin Zhang,1,* Lan Wang,2,* Dickson Kofi Wiredu Ocansey,1,3 Bo Wang,1 Li Wang,4 Zhiwei Xu1 1Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, People’s Republic of China; 2Danyang Blood S...
Guardado en:
Autores principales: | Zhang Y, Wang L, Ocansey DKW, Wang B, Xu Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/702ce4a8eacf4b2da29ff922a48af020 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nicotine-Free e-Cigarette Vapor Exposure Stimulates IL6 and Mucin Production in Human Primary Small Airway Epithelial Cells
por: Gellatly S, et al.
Publicado: (2020) -
Defensive Properties of Mucin Glycoproteins during Respiratory Infections—Relevance for SARS-CoV-2
por: Maitrayee Chatterjee, et al.
Publicado: (2020) -
Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek M, et al.
Publicado: (2021) -
The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Xu X, et al.
Publicado: (2021) -
The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane ER, et al.
Publicado: (2017)